WallStreetZenWallStreetZen

NASDAQ: VRTX
Vertex Pharmaceuticals Inc Stock Ownership - Who owns Vertex Pharmaceuticals?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Vertex Pharmaceuticals Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Joy LiuEVP and Chief Legal Officer2026-04-01978$449.17
$439.29kSell
Carmen BozicEVP and CMO2026-03-272,329$450.95
$1.05MSell
Carmen BozicEVP and CMO2026-03-132,329$481.79
$1.12MSell
Duncan McKechnieEVP Chief Commercial Officer2026-03-112,633$498.42
$1.31MSell
Duncan McKechnieEVP Chief Commercial Officer2026-03-042,437$475.30
$1.16MSell
Joy LiuEVP and Chief Legal Officer2026-03-02892$495.96
$442.40kSell
Carmen BozicEVP and CMO2026-02-272,329$480.31
$1.12MSell
Reshma KewalramaniCEO President2026-02-271,725$496.95
$857.24kSell
Reshma KewalramaniCEO President2026-02-275,995$496.16
$2.97MSell
Reshma KewalramaniCEO President2026-02-2715,580$495.38
$7.72MSell

1 of 14

VRTX insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when VRTX insiders and whales buy or sell their stock.

VRTX Shareholders

What type of owners hold Vertex Pharmaceuticals Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Capital World Investors10.04%25,510,182$11.14BInstitution
Vanguard Group Inc9.49%24,105,823$10.52BInstitution
Blackrock Inc9.35%23,751,989$10.37BInstitution
Capital Research Global Investors6.82%17,316,344$7.56BInstitution
State Street Corp4.60%11,689,539$5.10BInstitution
Jpmorgan Chase Co2.38%6,039,481$2.64BInstitution
Geode Capital Management LLC2.35%5,981,905$2.61BInstitution
Capital International Investors1.86%4,733,596$2.07BInstitution
Alliancebernstein LP1.77%4,496,482$1.96BInstitution
Loomis Sayles Co L P1.59%4,033,525$1.76BInstitution

1 of 3

VRTX vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
VRTX92.82%1.52%Net SellingNet Selling
REGN68.82%31.18%Net SellingNet Selling
ARGX48.47%0.00%
NVO7.06%0.00%
ALNY82.35%17.65%Net SellingNet Selling
View Top Biotech Stocks

Vertex Pharmaceuticals Stock Ownership FAQ

Who owns Vertex Pharmaceuticals?

Vertex Pharmaceuticals (NASDAQ: VRTX) is owned by 92.82% institutional shareholders, 1.52% Vertex Pharmaceuticals insiders, and 5.66% retail investors. Capital World Investors is the largest individual Vertex Pharmaceuticals shareholder, owning 25.51M shares representing 10.04% of the company. Capital World Investors's Vertex Pharmaceuticals shares are currently valued at $11.17B.

If you're new to stock investing, here's how to buy Vertex Pharmaceuticals stock.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.